BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1021220)

  • 1. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical routine gas chromatographic determination of phenobarbital, primidone and diphenylhydantoin.
    Malkus H; Jatlow PI; Castro A
    Clin Chim Acta; 1978 Jan; 82(1-2):113-7. PubMed ID: 618673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between dose and serum concentrations of carbamazepine, phenytoin, phenobarbital, and primidone in a Sri Lankan population compared with a European population.
    Peiris JB; Karunanayake EH; Joice PD; Goedhart DM; Meijer JW; Meinardi H
    Epilepsia; 1988; 29(5):564-70. PubMed ID: 3409842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amines, anticonvulsants, and epilepsy.
    Chadwick D; Jenner P; Reynolds EH
    Lancet; 1975 Mar; 1(7905):473-6. PubMed ID: 46954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticonvulsant level in saliva, serum, and cerebrospinal fluid.
    Troupin AS; Friel P
    Epilepsia; 1975 Jun; 16(2):223-7. PubMed ID: 1149709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.
    Kupferberg HJ
    Clin Chim Acta; 1970 Aug; 29(2):282-8. PubMed ID: 5493185
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum immunoglobulins in epilepsy.
    Slavin BN; Fenton GM; Laundy M; Reynolds EH
    J Neurol Sci; 1974 Nov; 23(3):353-7. PubMed ID: 4427121
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs.
    Braide SA; Davies TJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():391-9. PubMed ID: 2889417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in serum diphenylhydantoin levels after withdrawal of phenobarbital in epileptics treated with both drugs.
    Arakawa T; Yoshida T; Tanabu M; Karahashi M; Takagi T
    Tohoku J Exp Med; 1974 Feb; 112(2):165-8. PubMed ID: 4836028
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW; Schottelius DD
    J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved method for measurement of serum levels of phenobarbital, carbamazepine, primidone and diphenylhydantoin by gas-liquid chromatography.
    Nishina T; Okoshi K; Kitamura M
    Clin Chim Acta; 1976 Dec; 73(3):463-8. PubMed ID: 1000864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved method for the simultaneous determination of phenobarbital, primidone and diphenylhydantoin in patient's serum by gas-liquid chromatography.
    Davis HL; Falk KJ; Bailey DG
    J Chromatogr; 1975 Apr; 107(1):61-6. PubMed ID: 1141418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.